IMRX · Immuneering Corp · Webcasts, Transcripts & Audio
$4.11
+0.04 (+0.86%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$276.26M
Shares
64.70M
Volume · Oct 5
161.99K
Avg daily vol (3M)
715.19K
Immuneering Corp Webcasts
Earnings calls, investor updates, investor days and conferences for Immuneering Corp (IMRX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Earnings call
FY26 · Q1
2026-06-01
Immuneering Corp (IMRX) Q1 2026 Earnings Call
Diluted EPS
$-0.21
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q3
2025-11-12
Immuneering Corp (IMRX) Q3 2025 Earnings Call Transcript
Confident tone
Gemcitabine nab-paclitaxel combination and overall survival
Safety and tolerability / quality of life
Lung cancer and other tumor type expansion
Diluted EPS
$-0.38
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-18
Immuneering Corp (IMRX) Q1 2023 Earnings Call
Revenue
$
▼ 100% YoY Diluted EPS
$-0.51
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-06
Immuneering Corp (IMRX) Q4 2022 Earnings Call Transcript
Revenue
$455*
▼ 99.8% YoY Gross margin
100.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–4 of 4 webcasts